Monensin carry-over into unmedicated broiler feeds.

European Union Member States are now required to monitor poultry meat for the presence of coccidiostat residues. Among other factors contributing to the production of residue-free food is the ability of animal feed manufacturers to produce medication-free feedstuffs, ensuring the proper observance of withdrawal periods prior to slaughter. Carry-over of medication was investigated in a local poultry feed mill that was using monensin as its principal coccidiostat for broilers. Monensin, at levels in excess of 5% of the therapeutic dose (approximately 110 mg kg-1), was present in 22.5% of 40 withdrawal feeds. Subsequent studies in the mill indicated that most of the contamination occurred during the processing of feeds after the mixing stage. The mill altered its manufacturing process as a result of this study. The consequence of this was that the incidence of monensin withdrawal feeds, at levels greater than 5% of the therapeutic dose, fell from 22.5 to 2.5%. This collaborative study has helped the feed compounder to produce more effective withdrawal feeds, thereby reducing the potential exposure of consumers to unwanted residues of monensin in poultry meat.